Experts from Cerner Enviza provide a high level overview on utilizing Electronic Health Record (EHR) clinical data to support Real World Evidence (RWE) studies.
This presentation discusses the value of using EHR data as well as linking claims and EHR data to more effectively achieve your outcomes research study objectives. The speakers present each of these datasets and the key variables that distinguish them from other research datasets, thus providing a 360 view of the patient (ambulatory, in-patient, ER). Prospective longitudinal research can also be conducted directly from the EHR. Two case studies are also presented to better illustrate this value of these datasets.
Key Topics Include:
- Understanding the value of EHR data for performing RWE studies
- The unique characteristics of Cerner Enviza EHR Data in the context of support studies
- How linked EHR and claims can support studies
- How primary data collection efforts can be linked with EHR (or claims)
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
General Manager
Real World Evidence
Cerner Enviza
Andy Stankus leads the Real-World Evidence (RWE) team at Cerner Enviza. He has over 25 years of healthcare industry experience, including global markets such as Asia-Pacific, Europe, and the US. With his global track record and experience, he continues to innovate differentiated data assets and integrated solutions driving growth for global and regional clients.
General Manager, Medical Intelligence
Real World & Data Analytics
Cerner Enviza
Patricia Medina has over 20 years’ experience as a medical doctor, skilled in chronic disease management, health technology assessment, and evidence-based medicine. She is responsible for a team generating real-world evidence with secondary data sources.
Senior Evidence Generation Lead
Real World Evidence
Cerner Enviza
Jeffrey Thompson's role includes managing design, analysis, and interpretation of real-world evidence-based studies involving secondary retrospective data sources. Previously, Jeffery worked for CVS Health where he was responsible for performing start-to-finish analyses on multiple therapeutic classes.
Head
Clinical Development, Regulatory and Safety Products
Cerner Enviza
Ryan Moog is responsible for setting vision and driving strategy for Cerner Enviza's clinical research solutions, industry partnerships, and client relationships across the provider, academic, and Life Sciences industries. He leads teams focused on evolving Cerner's platform for collaborative research and data science, and in 2019 helped found the Learning Health Network (LHN).
Production Partner
Cerner Enviza
By combining decades of innovation, life sciences knowledge and collaborative research, Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable clarity to life sciences’ and healthcare’s most important decisions.
Additional Content From HealthEconomics.Com
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
Watch a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.
Related Content
Medicare Part D: Price Negotiation Panel Discussion
Hear expert panelists bring their perspectives on critical issues around support for Medicare Part D products' fair market prices.
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.